GRAL GRAIL, LLC

P/E --
Forward P/E 1.446
Price/Sales 42.67
Beta 2.838
Div Yield --
Market Cap --

Company Analysis

Latest News

πŸ”΄ GRAIL is trading 5.8% down in pre-market

GRAIL is trading at $148.68, down 5.83% in pre-market, with no confirmed company-specific announcement identified to explain the October 29 decline. - Its...

🟒 GRAIL is trading 5% up today as biotech gains offer a possible tailwind

GRAIL is trading 4.94% higher at $158.05, with biotech gains a possible tailwind, though its specific driver is unconfirmed. - No confirmed GRAIL-specific...

🟒 GRAIL is trading 5% up today with no confirmed GRAIL-specific catalyst

GRAIL is trading at $146.65, up +4.82%, with no confirmed company-specific explanation for the October 27 move. - Previously announced ESMO presentations...

🟒 GRAIL is trading 4.19% up today amid broader market gains

GRAIL is trading 4.19% higher at $138.10, with broader market sentiment a possible supportive backdrop, not a confirmed GRAIL-specific driver. - No confirmed...

🟒 GRAIL is trading 4.4% up today

GRAIL is trading at $132.65, up 4.40%, with no confirmed company-specific announcement or clearly linked catalyst explaining the October 23 gain. - GRAIL’s...

πŸ”΄ GRAIL is trading 4.24% down amid oil-fueled market retreat

GRAIL is trading $126.97, down 4.24%, amid a broad risk-off backdrop. - No fresh company-specific announcement explaining the October 22 decline surfaced in...

🟒 GRAIL is trading 5.7% up in pre-market amid XBI's 3.64% pre-market gain

GRAIL is trading 5.65% higher at $131.72 before the October 21, 2026, open, amid a broad biotech rally. - XBI is up 3.64% pre-market, alongside positive...

🟒 GRAIL rises 4.1% β€” Biotech Sector Surges on M&A Activity and Positive Clinical Trial Data

With Biotech (XBI) up 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector is experiencing a significant...

🟒 GRAIL, LLC is trading 7.82% up in pre-market

GRAL is trading at $131.99, up 7.82% in pre-market.

🟒 GRAIL is trading 4.47% up today β€” no clear new company-specific catalyst identified

GRAIL is trading at $123.08, up 4.47% on October 19, 2026, with no clear new company-specific catalyst identified for the move. - Recent coverage described the...

πŸ”΄ GRAIL is trading 10.13% down today amid reported profit-taking after roughly 85% one-month rally

GRAIL is trading at $121.74, down 10.13%, as coverage attributed pressure to profit-taking after a roughly 85% one-month rally. - No new GRAIL corporate...

πŸ”΄ GRAIL falls 4.3% β€” Biotech Sector Declines Amid Broad Market Rotation

With Biotech (XBI) down 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector, as represented by the XBI...

πŸ”΄ GRAIL is trading 4.3% down today amid rate concerns after hotter-than-expected inflation

GRAIL is trading 4.28% down at $133.57 as market concern that hotter-than-expected September inflation could keep interest rates higher weighs on shares. -...

πŸ”΄ GRAIL is trading 4.08% down in pre-market amid inflation-fueled rate concerns

GRAIL is trading 4.08% down at $134.00 in pre-market on October 15, with broader risk-off sentiment a possible backdrop; no new company-specific catalyst...

πŸ”΄ GRAIL is trading 4.3% down; cause remains unclear

GRAIL is trading 4.3% down at $134.51 on October 12; the specific reason for the decline remains unclear. - No reliable report identified a new...

🟒 GRAIL is trading 5% up with no clear catalyst identified

GRAIL is trading 5.17% higher at $139.47 on October 9, 2026, with no clear company-specific event identified to explain the move. - In pre-market, GRAIL was...

🟒 GRAIL, LLC is trading 8.68% up in pre-market

GRAL is trading at $144.12, up 8.68% in pre-market.

πŸ”΄ GRAIL is trading 4.2% down today amid macro and biotech-sector weakness

GRAIL is trading at $131.57, down 4.16%, amid broad market and biotech-sector weakness. - No clear negative company-specific catalyst has surfaced; the recent...

πŸ”΄ GRAIL is trading 10.25% down as the specific driver remains unclear

GRAIL is trading at $138.29, down 10.25%, with the specific driver of the October 6 decline unclear. - No reliable company-specific news was identified. GRAIL...

πŸ”΄ GRAIL is trading 4.3% down today

GRAIL is trading at $147.39 (-4.34%), with no reliable company-specific news found to explain the October 6 decline. - GRAIL announced new NHS-Galleri and...